Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4797154
Max Phase: Preclinical
Molecular Formula: C65H97N21O21S4
Molecular Weight: 1636.89
Molecule Type: Unknown
Associated Items:
ID: ALA4797154
Max Phase: Preclinical
Molecular Formula: C65H97N21O21S4
Molecular Weight: 1636.89
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]2CSSC[C@H](NC(=O)CN)C(=O)N[C@@H](CSSC[C@@H](C(N)=O)NC1=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N2
Standard InChI: InChI=1S/C65H97N21O21S4/c1-7-30(4)50-63(105)80-40(51(67)93)23-108-110-26-43-59(101)79-39(22-87)56(98)78-38(17-34-21-69-28-71-34)65(107)85-14-8-10-44(85)60(102)73-31(5)52(94)81-42(25-111-109-24-41(58(100)82-43)74-46(88)19-66)57(99)72-32(6)53(95)83-49(29(2)3)62(104)76-36(18-48(91)92)55(97)77-37(16-33-20-68-27-70-33)64(106)86-15-9-11-45(86)61(103)75-35(54(96)84-50)12-13-47(89)90/h20-21,27-32,35-45,49-50,87H,7-19,22-26,66H2,1-6H3,(H2,67,93)(H,68,70)(H,69,71)(H,72,99)(H,73,102)(H,74,88)(H,75,103)(H,76,104)(H,77,97)(H,78,98)(H,79,101)(H,80,105)(H,81,94)(H,82,100)(H,83,95)(H,84,96)(H,89,90)(H,91,92)/t30-,31-,32-,35-,36-,37-,38-,39-,40-,41-,42-,43-,44-,45-,49-,50-/m0/s1
Standard InChI Key: HUZCDRPMUZPBPS-GICDRNJKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1636.89 | Molecular Weight (Monoisotopic): 1635.6051 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Zhu X,Pan S,Xu M,Zhang L,Yu J,Yu J,Wu Y,Fan Y,Li H,Kasheverov IE,Kudryavtsev DS,Tsetlin VI,Xue Y,Zhangsun D,Wang X,Luo S. (2020) High Selectivity of an α-Conotoxin LvIA Analogue for α3β2 Nicotinic Acetylcholine Receptors Is Mediated by β2 Functionally Important Residues., 63 (22): [PMID:33196189] [10.1021/acs.jmedchem.0c00975] |
Source(1):